✦ LIBER ✦

Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C

✍ Scribed by Hitoshi Yoshiji; Ryuichi Noguchi; Hiroshi Fukui

Publisher: Springer Japan
Year: 2005
Tongue: English
Weight: 167 KB
Volume: 40
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-004-1523-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship of serum fibrosis markers w

Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C

✍ Robert J. Fontana; Zachary D. Goodman; Jules L. Dienstag; Herbert L. Bonkovsky; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

This study determined the utility of a panel of serum fibrosis markers along with routine laboratory tests in estimating the likelihood of histological cirrhosis in a cohort of prior nonresponders with chronic hepatitis C. The relationship between serum markers and quantitative hepatic collagen cont

Effect of interferon administration on s

Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C

✍ Kazuaki Chayama; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Toyomi Matsumoto; Yo 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

Hepatitis C virus RNA as detected by reverse transcription and nested polymerase chain reaction was monitored in 16 patients with chronic hepatitis C treated with interferon. Hepatitis C virus R N A became undetectable after 4 to 8 wk of interferon administration in 13 of the 16 patients. During 6 m

Simple blood tests as noninvasive marker

Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection

✍ Leonardo L. Schiavon; Janaína L. N. Schiavon; Roberto J. Carvalho Filho; Juliana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 2 views

HCV infection is common among patients with end-stage renal disease (ESRD) on hemodialysis, and it has been considered an independent risk factor for mortality in this setting. Although liver biopsy in ESRD patients with HCV infection is useful before kidney transplantation, it carries a high risk o

GB virus C (GBV-C) infection in patients

GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: Effect of interferon alfa therapy

✍ Pawlotsky, Jean-Michel; Roudot-Thoraval, Françoise; Muerhoff, A. Scott; Pellerin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 3 views

Effects of interferon treatment on liver

Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

✍ R. Todd Stravitz; Mitchell L. Shiffman; Arun J. Sanyal; Velimir A. Luketic; Rich 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 938 KB

Recurrent hepatitis C after liver transplantation remains a significant cause of graft loss and retransplantation. Although treatment of recurrent hepatitis C with interferon-based regimens has become widely accepted as safe and can lead to sustained virologic clearance of hepatitis C virus (HCV) RN

Effects of interferon on intrahepatic hu

Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C

✍ Takuro Hayata; Yoshiyuki Nakano; Kaname Yoshizawa; Takeshi Sodeyama; Kendo Kiyos 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 806 KB

We investigated the effects of interferon therapy on hepatocyte human leukocyte antigen class I and class I1 antigen expression and intrahepatic lymphocyte subsets in patients with chronic viral hepatitis B (n = 11) and C (n = 10). Interferon-a was administered intramuscularly in doses ranging from